According to AstraZeneca's latest financial reports the company's current earnings (TTM) are $2.38 B. In 2021 the company made an earning of $1.01 B a decrease over its 2020 earnings that were of $5.18 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | $2.38 B | 135.81% |
2021 | $1.01 B | -80.51% |
2020 | $5.18 B | 75.86% |
2019 | $2.95 B | -12.18% |
2018 | $3.35 B | -6.54% |
2017 | $3.59 B | -26.94% |
2016 | $4.91 B | 19.74% |
2015 | $4.10 B | 86.05% |
2014 | $2.20 B | -41.35% |
2013 | $3.76 B | -56.48% |
2012 | $8.65 B | -35.18% |
2011 | $13.34 B | 11.18% |
2010 | $12.00 B | |
2009 | $12.00 B | 31.29% |
2008 | $9.14 B | 12.97% |
2007 | $8.09 B | -1.48% |
2006 | $8.21 B | 26.36% |
2005 | $6.50 B | -2526.12% |
2004 | -$0.27 B | -106.52% |
2003 | $4.11 B | 2.94% |
2002 | $3.99 B | -32.95% |
2001 | $5.95 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $22.51 B | 844.59% | ๐บ๐ธ USA |
![]() Novartis NVS | $23.58 B | 889.14% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $34.92 B | 1,364.89% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $9.31 B | 290.65% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $6.54 B | 174.74% | ๐บ๐ธ USA |
![]() Sanofi SNY | $8.65 B | 262.97% | ๐ซ๐ท France |
![]() Biogen BIIB | $3.39 B | 42.32% | ๐บ๐ธ USA |
![]() Merck MRK | $17.77 B | 645.64% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $7.71 B | 223.49% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $6.58 B | 176.17% | ๐ฌ๐ง UK |